P2Y2 receptors regulate multiple signal transduction pathways in monocytic cells

Activation of P2Y2 receptors by extracellular nucleotides induces cellular responses required for differentiation of human promonocytic U937 cells. Multiple signal transduction pathways are independently coupled to P2Y2 receptors in U937 cells, including stimulation of phospholipase C (PLC)‐dependent calcium mobilization and phosphorylation of mitogen‐activated protein (MAP) kinases. In U937 cells, P2Y2 receptors couple to the MAP kinases MEK1/2 and ERK1/2 via phosphatidylinositol 3‐kinase (PI3‐K) and c‐Src. ERK1/2 phosphorylation induced by UTP was inhibited by the PI3‐K inhibitors wortmannin and LY294002, the c‐Src inhibitors radicicol and PP2, and the inhibitor of actin polymerization, cytochalasin D, but not by inhibitors of calcium‐dependent protein kinase C isoforms. The phosphorylation of ERK1/2 induced by UTP was independent of calcium mobilization, since chelation of intracellular calcium with BAPTA had no effect. The importance of multiprotein complexes in mediating G‐protein‐coupled receptor signaling has recently been recognized. Studies with an epitope‐tagged P2Y2 receptor expressed in human 1321N1 astrocytoma cells indicated that activation of the P2Y2 receptor with UTP causes it to colocalize with the EGF receptor. The P2Y2 receptor also contains the consensus integrin‐binding motif arginine‐glycine‐aspartic acid (RGD) in its first extracellular loop that was hypothesized to promote interactions with integrins. Results of immunofluorescence and peptide binding experiments suggest that wild‐type, RGD‐containing receptors, but not RGE mutant receptors, can form complexes with αVβ3/β5 integrins and the integrin‐associated thrombospondin receptor (CD47). Compared to wild‐type P2Y2 receptors, RGE mutant receptors required 1,000‐fold higher concentrations of ATP or UTP to activate PLC‐dependent calcium mobilization and the phosphorylation of focal adhesion kinase (FAK) and ERK1/2. Competition studies indicated that an RGDS peptide inhibited the P2Y2 receptor‐mediated phosphorylation of FAK and ERK1/2. These findings suggest that the RGD domain of the P2Y2 receptor is required to promote efficient coupling to intracellular signaling pathways. Thus, P2Y2 receptors regulate divergent signal transduction pathways that are dependent on the formation of multiprotein complexes including EGF receptors and integrins. Our studies encourage further attempts to develop strategies to independently regulate these pathways at steps proximal to P2Y2 receptors. Drug Dev. Res. 53:186–192, 2001. © 2001 Wiley‐Liss, Inc.

[1]  G. Weisman,et al.  P2Y2 nucleotide receptor signaling in human monocytic cells: Activation, desensitization and coupling to mitogen‐activated protein kinases , 2001, Journal of cellular physiology.

[2]  J. T. Turner,et al.  An Rgd Sequence in the P2y2 Receptor Interacts with αVβ3 Integrins and Is Required for Go-Mediated Signal Transduction , 2001, The Journal of cell biology.

[3]  R. Lefkowitz,et al.  The β2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.

[4]  J. Neary,et al.  Mitogenic Signaling by ATP/P2Y Purinergic Receptors in Astrocytes: Involvement of a Calcium-Independent Protein Kinase C, Extracellular Signal-Regulated Protein Kinase Pathway Distinct from the Phosphatidylinositol-Specific Phospholipase C/Calcium Pathway , 1999, The Journal of Neuroscience.

[5]  R. Lefkowitz,et al.  Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade , 1999, The Journal of Biological Chemistry.

[6]  E. Brown,et al.  The Thrombospondin Receptor Integrin-associated Protein (CD47) Functionally Couples to Heterotrimeric Gi * , 1999, The Journal of Biological Chemistry.

[7]  J. T. Turner,et al.  Structural Basis of Agonist-induced Desensitization and Sequestration of the P2Y2 Nucleotide Receptor , 1998, The Journal of Biological Chemistry.

[8]  G. Weisman,et al.  P2Y nucleotide receptors in the immune system: Signaling by a P2Y2 receptor in U937 monocytes , 1998 .

[9]  S. Soltoff Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor , 1998, The Journal of Biological Chemistry.

[10]  K. Berg,et al.  The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. , 1998, Journal of immunology.

[11]  N. Ahn,et al.  Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[12]  J. T. Turner,et al.  Salivary Gland Nucleotide Receptors: Changes in Expression and Activity Related to Development and Tissue Damage a, , 1998, Annals of the New York Academy of Sciences.

[13]  F. Sistare,et al.  Distribution of P2Y receptor subtypes on haematopoietic cells , 1998, British journal of pharmacology.

[14]  L. Cantley,et al.  Activation of P2Y2 Receptors by UTP and ATP Stimulates Mitogen-activated Kinase Activity through a Pathway That Involves Related Adhesion Focal Tyrosine Kinase and Protein Kinase C* , 1998, The Journal of Biological Chemistry.

[15]  K. Jacobson,et al.  P2 Receptor Modeling and Identification of Ligand Binding Sites , 1998 .

[16]  J. T. Turner,et al.  The Cloning and Expression of G Protein-Coupled P2Y Nucleotide Receptors , 1998 .

[17]  J. T. Turner,et al.  Upregulation of P2Y2 nucleotide receptors in rat salivary gland cells during short-term culture. , 1997, The American journal of physiology.

[18]  J. T. Turner,et al.  Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Dubyak,et al.  Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. , 1997, Molecular pharmacology.

[20]  H. Gresham,et al.  Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding , 1996, The Journal of cell biology.

[21]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[22]  J. T. Turner,et al.  Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.

[23]  J. T. Turner,et al.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Dubyak,et al.  ATP-induced potentiation of G-protein-dependent phospholipase D activity in a cell-free system from U937 promonocytic leukocytes. , 1993, The Journal of biological chemistry.

[25]  D. Julius,et al.  Expression cloning of an ATP receptor from mouse neuroblastoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Melvin Berger,et al.  Chronic Treatment With P2‐Purinergic Receptor Agonists Induces Phenotypic Modulation of the HL‐60 and U937 Human Myelogenous Leukemia Cell Lines , 1991, Journal of leukocyte biology.

[27]  D. S. Cowen,et al.  Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. , 1989, The Journal of clinical investigation.

[28]  P. Ralph,et al.  Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. , 1985, Cancer research.

[29]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.